Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 31.10 | 25.57 | 161.57 | 21.27 |
Depreciation/ Depletion | 19.56 | 14.96 | 10.69 | 6.49 |
Non- Cash Items | 17.06 | 5.99 | 2.87 | 2.60 |
Changesin Working Capital | -24.74 | -5.14 | -114.53 | -3.66 |
Cashfrom Operating Activities | 42.98 | 41.38 | 60.60 | 26.71 |
Capital Expenditures | -29.84 | -47.67 | -55.15 | -23.40 |
Other Investing Cash Flow Items Total | 3.44 | -0.77 | -7.78 | 0.20 |
Cashfrom Investing Activities | -26.40 | -48.44 | -62.93 | -23.20 |
Financing Cash Flow Items | -10.20 | -6.02 | -2.92 | -2.67 |
Issuance( Retirement)of Debt Net | -7.20 | 7.01 | 8.57 | 3.44 |
Cashfrom Financing Activities | -17.40 | 0.99 | 5.66 | 0.77 |
Net Changein Cash | -0.81 | -6.07 | 3.33 | 4.27 |
Cash Interest Paid | 10.20 | 6.02 | 2.92 | 2.67 |
Cash Taxes Paid | 1.30 | 6.16 | 41.35 | 6.38 |
Kwality Pharmaceuticals Dividend Kwality Pharmaceuticals Bonus Kwality Pharmaceuticals News Kwality Pharmaceuticals AGM Kwality Pharmaceuticals Rights Kwality Pharmaceuticals Splits Kwality Pharmaceuticals Board Meetings Kwality Pharmaceuticals Key Metrics Kwality Pharmaceuticals Shareholdings Kwality Pharmaceuticals Profit Loss Kwality Pharmaceuticals Balance Sheet Kwality Pharmaceuticals Q1 Results Kwality Pharmaceuticals Q2 Results Kwality Pharmaceuticals Q3 Results Kwality Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks